US drug giant halts Celebrex advertising

Drug giant Pfizer is to stop advertising its best-selling arthritis pain reliever Celebrex after a study showed high doses of it were associated with an increased heart attack risk.

The move covered television, radio, newspaper and magazine advertising, Pfizer spokeswoman Mariann Caprino said.